In both B-cell and T-cell acute lymphoblastic leukemia (ALL), SEs dysregulation drives transformation by overexpressing oncogenes like MYC and TAL1, often through alterations in lineage-specific transcription factors. This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.